Premature ovarian failure: Present aspects;Falência ovariana prematura: Aspectos atuais

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 6, 2007, Pages 920-929

  Vilodre, Luiz Cesar ^a   Moretto, Marcelo ^a   Da Fonte Kohek, Maria Beatriz ^b   Spritzer, Poli Mara ^a,c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Estrogen; Hormonal therapy; Hypergonadotrophic hypogonadism; Infertility; Premature ovarian failure

Indexed keywords

EID: 35848970033     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000600005     Document Type: Review

References (55)

1. Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril 1967;18(4):440-61.
2. Johnson TR Jr, Peterson EP. Gonadotropin-induced pregnancy following "premature ovarian failure". Fertil Steril 1979;31(3):351-2.
3. Lucky AW, Rebar RW, Blizzard RM, Goren EM. Pubertal progression in the presence of elevated serum gonadotropins in girls with multiple endocrine deficiencies. J Clin Endocrinol Metab 1977;45(4):673-8.
4. Anasti JN. Premature ovarian failure: an update. Fertil Steril 1998;70(1):1-15.
5. Van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5:483-92.
6. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update 2005;11(4):391-410.
7. Nelson LM, Covington SN, Rebar RW. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 2005;83(5):1327- 32.
8. Vilodre LC, Kohek MBF, Spritzer PM. Screening of FSH receptor gene in women with premature ovarian failure (POF) in southern Brazil and associations with phenotype. P1-337, Annals of the 89th Endo Soc Meeting, Toronto, Canada, June 2-5, 2007.
9. Simpson JL, Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet 1999;89(4):186-200.
10. Loughlin SA, Redha A, McIver J, Boyd E, Carothers A, Connor JM. Analysis of the origin of Turner's syndrome using polymorphic DNA probes. J Med Genet 1991;28(3):156-8.
11. Goswami R, Goswami D, Kabra M, Gupta N, Dubey S, Dadhwal V. Prevalence of the triple X syndrome in phenotypically normal women with premature ovarian failure and its association with autoimmune thyroid disorders. Fertil Steril 2003;80(4):1052-4.
12. Therman E, Laxova R, Susman B. The critical region on the human Xq. Hum Genet 1990;85(5):455-61.
13. Powell CM, Taggart RT, Drumheller TC, Wangsa D, Qian C, Nelson LM, et al. Molecular and cytogenetic studies of an X;autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet 1994;52(1):19-26.
14. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998;13(5):1184-7.
15. Hundscheid RD, Sistermans EA, Thomas CM, Braat DD, Straatman H, Kiemeney LA. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am J Hum Genet 2000;66(2):413-8.
16. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 1998;12(12):1809-17.
17. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, Cavallo L, et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 2006;91(5):1976-9.
18. Oley C, Baraitser M. Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES syndrome). J Med Genet 1988;25(1):47-51.
19. Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990;13(6):802-18.
20. Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Premature ovarian failure in galactosaemia: pathophysiology and clinical management. Pathol Biol (Paris) 2003;51:47-56.
21. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002;23(3):327-64.
22. Laml T, Preyer O, Umek W, Hengstschlager M, Hanzal E. Genetic disorders in premature ovarian failure. Hum Reprod Update 2002;8(4):483-91.
23. Matthijs G, Schollen E, Pardon E, Veiga da Cunha M, Jaeken J, Cassiman J, et al. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet 1997;16:88-92.
24. Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82(6):959-68.
25. Rousseau-Merck MF, Atger M, Loosfelt H, Milgrom E, Berger R. The chromosomal localization of the human follicle-stimulating hormone receptor gene (FSHR) on 2p21-p16 is similar to that of the luteinizing hormone receptor gene. Genomics 1993;15(1):222-4.
26. Aittomaki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 1996;81(10):3722-6.
27. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchasky C, et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest 1998;102(7):1352-9.
28. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol 1999;13(11):1844-54.
29. Doherty E, Pakarinen P, Tiitinen A, Kiilavuori A, Huhtaniemi I, Forrest S, et al. A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab 2002;87(3):1151-5.
30. Allen LA, Achermann JC, Pakarinen P, Kotlar TJ, Huhtaniemi IT, Jameson JL, et al. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics. Hum Reprod 2003;18(2):251-6.
31. Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC, et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab 2003;88(8):3491-8.
32. da Fonte Kohek MB, Batista MC, Russell AJ, Vass K, Giacaglia LR, Mendonça BB, et al. No evidence of the inactivating mutation (C566T) in the follicle-stimulation hormone receptor gene in Brazilian women with premature ovarian failure. Fertil Steril 1998;70(3):565-7.
33. Sundblad V, Chiauzzi VA, Escobar ME, Dain L, Charreau EH. Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Mol Cell Endocrinol 2004;222(1/2):53-9.
34. Latronico AC, Anasti J, Amhold IJ, Rapaport R, Mendonça BB, Bloisse W, et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996;334(8):507-12.
35. MacNaughton J, Banah M, McCloud P, Hee J, Burger H. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age. Clin Endocrinol (Oxf) 1992;36(4):339-45.
36. Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM, et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 2000;15(12):2644-9.
37. Conway GS. Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol (Oxf) 1996;45(6):657-63.
38. Sedmak DD, Hart WR, Tubbs RR. Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int J Gynecol Pathol 1987;6(1):73-81.
39. Eisenbarth GS. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350:2068-79.
40. Society of Obstetricians and Gynaecologists of Canada (SOGC) clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004. J Gynaecol Obstet 2005;89(3):305-18.
41. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001;28(4):355-60.
42. Bastos CA, Lisboa KO, Fuchs SC, Donato GB, Spritzer PM. Determinants of ovarian pre- menopausal transition and postmenopausal women: a population based study. Maturitas 2005;53(4):405-12.
43. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994;79(5):1470-5.
44. Massin N, Gougeon A, Meduri G, Thibaud E, Laborde K, Matuchansky C, et al. Significance of ovarian histology in the management of patients presenting a premature ovarian failure. Hum Reprod 2004;19(11):2555-60.
45. Henzl MR, Loomba PK. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. J Reprod Med 2003;48(7):525-40.
46. Vilodre LC, Wender MC, Castro JA, Reis FM, Ruschel S, Magalhães JA, et al. Endometrial response to cyclic regimen of percutaneous 17-β-estradiol and low-dose vaginal micronized progesterone in women with mild to moderate hypertension. Gynecol Endocrinol 2003;17(4):323-8.
47. Jones SC. Subcutaneous estrogen replacement therapy. J Reprod Med 2004;49(3):139-42.
48. a ed. Belo Horizonte: Coopmed, 2007 [no prelo].
49. Hartmann BW, Kirchengast S, Albrecht A, Laml T, Soregi G, Huber JC. Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecol Obstet Invest 1997;44:127-31.
50. Bachelot A, Meduri G, Massin N, Misrahi M, Kuttenn F, Touraine P. Ovarian steroidogenesis and serum androgen levels in patients with premature ovarian failure. J Clin Endocrinol Metab 2005;90(4):2391-6.
51. Check JH, Chase JS, Spence, M. Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy. Am J Obstet Gynecol 1989;160(1):114-5.
52. Paulson RJ, Hatch IE, Lobo RA, Sauer MV. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997;12(4):835-9.
53. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364(9443):1405-10.
54. Eastell R. Management of osteoporosis due to ovarian failure. Med Pediatr Oncol 2003;41(3):222-7.
55. Kalantaridou SN, Naka KK, Bechlioulis A, Makrigiannakis A, Michalis L, Chrousos GP. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement. Trends Endocrinol Metab 2006;17(3):101-9.